The polypill: the solution for prevention of coronary heart disease?

Main Article Content

Hendarto Natadidjaja


In Western countries, cardiovascular disease is the most common cause of death and it is expected that it will continue to be so in the near future.(1) If the resulting physical impairment and psychosocial disturbances are also taken into account, clearly this is a serious problem from the viewpoint of productivity, quality of life, as well as community health level. Therefore the institution of preventive measures is an important issue. Unfortunately, however, currently preventive measures that are effective, safe, and at the same time practical and economical, are almost nonexistent.

Article Details

How to Cite
Natadidjaja, H. (2009). The polypill: the solution for prevention of coronary heart disease?. Universa Medicina, 28(2), i-ii. Retrieved from
Review Article


Ezzati M, Hoorn SV, Rodgers A, Lopez AD, Mathers CD, Murray CJ. Estimates of global and regional potential health gains from reducing multiple major risk factors. Lancet 2003:362:271-80.

Panchin N, Cambon JP, Hanama G, Kadri Z, Genes N, Cablanche JM, et al. USIC 2000 Investigators. Impact of combined secondary prevention therapy after acute myocardial infarction: data from a nationwide French registry. Am Heart J 2005;150:1147-53.

Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ 2003;326:1419.

Sleight P, Pouleur H, Zannad F. Benefits, challenges, and registerability of the polypill. European Heart Journal 2006;27:1651–6.